APLIF: DSMB Recommends for PRESECO Trial to Complete; Data Expected in 3Q21… msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
On Friday, March 5, Health Canada authorized the COVID-19 vaccine manufactured by Janssen Inc. Health Canada received an application from Janssen Inc. for authorization of its COVID-19 vaccine on November
Today, Health Canada authorized the COVID-19 vaccine manufactured by Janssen Inc.
Health Canada received an application from Janssen Inc. for authorization of its COVID-19 vaccine on November 30, 2020. After a thorough, independent review of the evidence, the Department has determined that the vaccine meets Canada s stringent safety, efficacy and quality requirements.
The Janssen vaccine is the first single-dose COVID-19 vaccine to be authorized in Canada, and can be stored and transported at refrigerated temperatures (from 2˚ to 8˚C) for at least three months, facilitating distribution across the country. The vaccine is authorized for use in people over 18 years of age, and is a viral vector-based COVID-19 vaccine.
Share this article
Share this article
OTTAWA, ON, Feb. 26, 2021 /CNW/ - Today, Health Canada authorized two vaccines; the COVID-19 vaccine manufactured by AstraZeneca, and developed in partnership with Oxford University, and, the Serum Institute of India s version of the AstraZeneca vaccine.
Health Canada received an application for authorization from AstraZeneca on October 1, 2020, and from Verity Pharmaceuticals Inc./Serum Institute of India (in partnership with AstraZeneca Canada Inc.) on January 23, 2021. After thorough, independent reviews of the evidence, the Department has determined that these vaccines meet Canada s stringent safety, efficacy and quality requirements.
Health Canada s authorization of the Verity Pharmaceuticals Inc./Serum Institute of India product relies on the assessment of its comparability to the AstraZeneca-produced version of the vaccine.
From: Health Canada
December 23, 2020 Ottawa, ON Health Canada
Today, Health Canada authorized the second COVID-19 vaccine in Canada, manufactured by Moderna.
Health Canada received Moderna’s submission on October 12, 2020, and after a thorough, independent review of the evidence, it has determined that the Moderna vaccine meets the Department’s stringent safety, efficacy and quality requirements.
Today’s authorization is a critical step in ensuring additional COVID-19 vaccines are available to all Canadians in all parts of the country. The different storage and handling requirements of the Moderna COVID-19 vaccine mean that it can be distributed to isolated and remote communities, including the territories.